Sina Ahmadi

Dr. Sina Ahmadi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
SDShaojie Dong
Shaojie Dong
Yuwei ZhangYuwei Zhang
Yuwei Zhang
YZYifei Zhang
Yifei Zhang
YMYukun Mei
Yukun Mei
SASina Ahmadi
Sina Ahmadi
LNLin Niu
Lin Niu
Considering the high recrudescence and the long-lasting unhealed large-sized wound that affect the aesthetics and cause dysfunction after resection of maxillofacial malignant skin tumors, a groundbreaking strategy is urgently needed. Photothermal therapy (PTT), which has become a complementary treatment of tumors, however, is powerless in tissue defect regeneration. Therefore, a novel multifunctional sodium nitroprusside and Fe2+ ions loaded microneedles (SNP-Fe@MNs) platform was fabricated by accomplishing desirable NIR-responsive photothermal effect while burst releasing nitric oxide (NO) after the ultraviolet radiation for the ablation of melanoma. Moreover, the steady releasing of NO in the long term by the platform can exert its angiogenic effects via upregulating multiple related pathways to promote tissue regeneration. Thus, the therapeutic dilemma caused by postoperative maxillofacial skin malignancies could be conquered through promoting tumor cell apoptosis via synergistic PTT—gas therapy and subsequent regeneration process in one step. The bio-application of SNP-Fe@MNs could be further popularized based on its ideal bioactivity and appealing features as a strategy for synergistic therapy of other tumors occurred in skin. Graphical Abstract

16 October 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
XFXu Fangfang
Xu Fangfang
GYGong Yuxin
Gong Yuxin
SASina Ahmadi
Sina Ahmadi
WCWang Chunyan
Wang Chunyan
PAPouria Arian
Pouria Arian
SNSijia Na
Sijia Na
This study aimed to evaluate the clinical efficacy of applying real-time dynamic navigation (RDN) in the extraction of deep horizontal mandibular impacted third molars, hypothesizing that RDN reduces surgical time and minimizes the risk of injury to adjacent anatomical structures. A prospective study was conducted on 160 patients aged between 18 and 37 years with deep horizontal impaction of the mandibular third molar. The participants were randomly assigned to either the experimental group (receiving RDN-assisted extractions) or the control group (undergoing traditional extraction methods). Preoperative planning utilized cone beam computed tomography (CBCT) and Mimics software for the accurate localization and segmentation of impacted teeth. Parametric data were analysed via an independent t test for intergroup comparisons, and significance was set to p < 0.05. In the experimental group, an average of 11 ± 1 min was required for preoperative planning via RDN, which was not required in the control group. The setup of the navigation system took an average of 4 ± 1 min in the experimental group and 0 min in the control group. The experimental group demonstrated a significantly shorter average surgical time (22 ± 3 min) than did the control group (36 ± 3 min). The differences in the preoperative design time, surgical time, and complication rates between the two groups were statistically significant (p = 0.005). Additionally, the RDN group reported no complications related to adjacent tooth damage or nerve injury. The precision, safety, real-time guidance of RDN supports its use in complicated dental extractions, which would introduce a new era of oral and maxillofacial surgery.

30 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JLJing Li
Jing Li
YZYifei Zhu
Yifei Zhu
XYXie Lin Yang
Xie Lin Yang
SASina Ahmadi
Sina Ahmadi
CYChonghao Yao
Chonghao Yao
SNSijia Na
Sijia Na
Objective: To explore the role and mechanism of miR-27b-3p in treating infantile hemangiomas (IHs) with propranolol and to clarify the cause of the poor efficacy of propranolol in IHs. Methods: Human umbilical vein endothelial cells (HUVECs) were used as the research model and were treated with 0, 15, 30, 45, 60, and 90 μM of propranolol to explore the best concentration. RNA interference technology was used to regulate the expression of miR-27b-3p. CCK-8, TUNEL, and flow cytometry detected cell proliferation and apoptosis levels. Real-time PCR was used to detect the expression of miR-27b-3p and apoptosis pathway-related mRNA, and Western blotting was used to detect the expression of apoptosis-related proteins. The target relationship between miR-27b-3p and Apaf-1 was analyzed using a double Luciferase report. Results: The most significant inhibitory effect on cell activity of propranolol is at a dose of 30 μM. After propranolol treatment, the expression of miR-27b-3p was downregulated, and the expression of the apoptotic factors Apaf-1, PARP, caspase-9, and caspase-3 was upregulated, which was consistent with the results after the deletion of miR-27b-3p. However, after upregulation of miR-27b-3p, the level of and the expression of apoptotic factors was inhibited. “targetscan.org” gene database analysis found that miR-27b-3p matched the 3′-UTR of Apaf-1 mRNA, and luciferase results showed that miR-27b-3p had a targeted relationship with Apaf-1. Conclusions: The miR-27b-3p target inhibits the expression of Apaf-1, reduces the level of endothelial cell apoptosis, and interferes with the therapeutic effect of propranolol.

15 October 2025
Verified
Book Chapter
Open access
PDF file
Elahe Aleebrahim-DehkordiElahe Aleebrahim-Dehkordi
Elahe Aleebrahim-Dehkordi
MDMahmoud Bahrami Dashtaki
Mahmoud Bahrami Dashtaki
SASina Ahmadi
Sina Ahmadi
In temporomandibular joint (TMJ) disorders, inflammation is accompanied by pain and cartilage degeneration. This pain may be caused by temporomandibular disorders due to muscular or joint conditions, or both. However, it is not clear which non-invasive treatments work best. In the treatment of this disorder, there are two main options for pharmacological management of pain, one of which is the use of nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs stop the production of prostaglandins, which is why NSAIDs, by inhibiting the enzyme, reduce the production of prostaglandins and reduce inflammation. NSAIDs are now one of the first-line treatments for mild-to-moderate inflammatory pain in patients with TMJ because of their strong analgesic and anti-inflammatory properties, including the capacity to inhibit cyclooxygenase and hence prevent prostaglandin formation. This chapter provides a comprehensive classification of TMJ and then goes on to discuss the NSAIDs’ mechanism of action, administration, side effects, contraindications, management, and monitoring. It also covers crucial information for healthcare professionals. Since topical NSAIDs have minimal gastrointestinal effects, they might be safe for treating TMJ. Considering their risk-benefit ratio in relation to alternative anti-TMJ therapies, topical NSAIDs should be considered for TMJ. Effective treatment for TMD requires a multidisciplinary approach between dentists, pain specialists, physiotherapists, psychologists and neurologists. NSAIDs these drugs are among the successful treatment options in reducing pain and inflammation in TMJ disease. It is highly advised to use NSAIDs at the lowest effective dose for the shortest amount of time, and to reduce the gastrointestinal risk of associated with NSAIDs, should be supplementary gastroprotective agent’s medications prescribed.


3 November 2026
Verified
Book Chapter
Closed access
DSDorsa Samani
Dorsa Samani
NGNarin Gharehdaghi
Narin Gharehdaghi
NGNikoo Ghasemi
Nikoo Ghasemi
JBJeiran Babayani
Jeiran Babayani
SSSina Sadeghi
Sina Sadeghi
SASina Ahmadi
Sina Ahmadi